Regulated Electric
Compare Stocks
2 / 10Stock Comparison
CMSA vs CNP
Revenue, margins, valuation, and 5-year total return — side by side.
Regulated Electric
CMSA vs CNP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Regulated Electric | Regulated Electric |
| Market Cap | $6.63B | $27.58B |
| Revenue (TTM) | $8.54B | $9.41B |
| Net Income (TTM) | $1.07B | $1.07B |
| Gross Margin | 60.9% | 41.3% |
| Operating Margin | 20.2% | 22.5% |
| Forward P/E | 5.7x | 21.9x |
| Total Debt | $18.94B | $23.66B |
| Cash & Equiv. | $615M | $49M |
CMSA vs CNP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CMS Energy Corporat… (CMSA) | 100 | 83.9 | -16.1% |
| CenterPoint Energy,… (CNP) | 100 | 234.6 | +134.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CMSA vs CNP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CMSA carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 19 yrs, beta 0.73, yield 10.0%
- Rev growth 13.6%, EPS growth 6.0%, 3Y rev CAGR -0.2%
- Lower volatility, beta 0.73, current ratio 0.98x
CNP is the clearest fit if your priority is long-term compounding.
- 135.8% 10Y total return vs CMSA's 33.2%
- +10.4% vs CMSA's +9.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.6% revenue growth vs CNP's 8.3% | |
| Value | Lower P/E (5.7x vs 21.9x) | |
| Quality / Margins | 12.5% margin vs CNP's 11.4% | |
| Stability / Safety | Lower D/E ratio (195.0% vs 212.2%) | |
| Dividends | 10.0% yield, 19-year raise streak, vs CNP's 2.1% | |
| Momentum (1Y) | +10.4% vs CMSA's +9.8% | |
| Efficiency (ROA) | 2.8% ROA vs CNP's 2.3%, ROIC 4.9% vs 4.8% |
CMSA vs CNP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CMSA vs CNP — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CMSA leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CNP and CMSA operate at a comparable scale, with $9.4B and $8.5B in trailing revenue. Profitability is closely matched — net margins range from 12.5% (CMSA) to 11.4% (CNP). On growth, CMSA holds the edge at +12.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $8.5B | $9.4B |
| EBITDAEarnings before interest/tax | $2.9B | $3.7B |
| Net IncomeAfter-tax profit | $1.1B | $1.1B |
| Free Cash FlowCash after capex | -$1.6B | -$2.7B |
| Gross MarginGross profit ÷ Revenue | +60.9% | +41.3% |
| Operating MarginEBIT ÷ Revenue | +20.2% | +22.5% |
| Net MarginNet income ÷ Revenue | +12.5% | +11.4% |
| FCF MarginFCF ÷ Revenue | -18.6% | -28.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +12.3% | +1.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +6.8% | +6.7% |
Valuation Metrics
CMSA leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 6.2x trailing earnings, CMSA trades at a 76% valuation discount to CNP's 26.4x P/E. On an enterprise value basis, CMSA's 8.7x EV/EBITDA is more attractive than CNP's 14.1x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $6.6B | $27.6B |
| Enterprise ValueMkt cap + debt − cash | $25.0B | $51.2B |
| Trailing P/EPrice ÷ TTM EPS | 6.25x | 26.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 5.72x | 21.85x |
| PEG RatioP/E ÷ EPS growth rate | 1.04x | — |
| EV / EBITDAEnterprise value multiple | 8.67x | 14.06x |
| Price / SalesMarket cap ÷ Revenue | 0.78x | 2.95x |
| Price / BookPrice ÷ Book value/share | 0.68x | 2.48x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
CMSA leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
CMSA delivers a 11.6% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $10 for CNP. CMSA carries lower financial leverage with a 1.95x debt-to-equity ratio, signaling a more conservative balance sheet compared to CNP's 2.12x. On the Piotroski fundamental quality scale (0–9), CMSA scores 6/9 vs CNP's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +11.6% | +9.6% |
| ROA (TTM)Return on assets | +2.8% | +2.3% |
| ROICReturn on invested capital | +4.9% | +4.8% |
| ROCEReturn on capital employed | +5.0% | +5.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 3 |
| Debt / EquityFinancial leverage | 1.95x | 2.12x |
| Net DebtTotal debt minus cash | $18.3B | $23.6B |
| Cash & Equiv.Liquid assets | $615M | $49M |
| Total DebtShort + long-term debt | $18.9B | $23.7B |
| Interest CoverageEBIT ÷ Interest expense | 2.58x | 2.38x |
Total Returns (Dividends Reinvested)
CNP leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CNP five years ago would be worth $18,832 today (with dividends reinvested), compared to $10,772 for CMSA. Over the past 12 months, CNP leads with a +10.4% total return vs CMSA's +9.8%. The 3-year compound annual growth rate (CAGR) favors CNP at 13.9% vs CMSA's 1.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +0.9% | +9.7% |
| 1-Year ReturnPast 12 months | +9.8% | +10.4% |
| 3-Year ReturnCumulative with dividends | +5.9% | +47.9% |
| 5-Year ReturnCumulative with dividends | +7.7% | +88.3% |
| 10-Year ReturnCumulative with dividends | +33.2% | +135.8% |
| CAGR (3Y)Annualised 3-year return | +1.9% | +13.9% |
Risk & Volatility
CNP leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CNP is the less volatile stock with a -0.03 beta — it tends to amplify market swings less than CMSA's 0.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CNP currently trades 95.0% from its 52-week high vs CMSA's 89.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.74x | -0.06x |
| 52-Week HighHighest price in past year | $24.67 | $44.47 |
| 52-Week LowLowest price in past year | $6.11 | $35.46 |
| % of 52W HighCurrent price vs 52-week peak | +89.4% | +95.0% |
| RSI (14)Momentum oscillator 0–100 | 68.9 | 44.4 |
| Avg Volume (50D)Average daily shares traded | 14K | 4.5M |
Analyst Outlook
CMSA leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
For income investors, CMSA offers the higher dividend yield at 10.00% vs CNP's 2.07%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $43.67 |
| # AnalystsCovering analysts | — | 30 |
| Dividend YieldAnnual dividend ÷ price | +10.0% | +2.1% |
| Dividend StreakConsecutive years of raises | 19 | 4 |
| Dividend / ShareAnnual DPS | $2.21 | $0.88 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
CMSA leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). CNP leads in 2 (Total Returns, Risk & Volatility).
CMSA vs CNP: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CMSA or CNP a better buy right now?
For growth investors, CMS Energy Corporation 5.
6% JRSUB NT 78 (CMSA) is the stronger pick with 13. 6% revenue growth year-over-year, versus 8. 3% for CenterPoint Energy, Inc. (CNP). CMS Energy Corporation 5. 6% JRSUB NT 78 (CMSA) offers the better valuation at 6. 2x trailing P/E (5. 7x forward), making it the more compelling value choice. Analysts rate CenterPoint Energy, Inc. (CNP) a "Hold" — based on 30 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CMSA or CNP?
On trailing P/E, CMS Energy Corporation 5.
6% JRSUB NT 78 (CMSA) is the cheapest at 6. 2x versus CenterPoint Energy, Inc. at 26. 4x. On forward P/E, CMS Energy Corporation 5. 6% JRSUB NT 78 is actually cheaper at 5. 7x.
03Which is the better long-term investment — CMSA or CNP?
Over the past 5 years, CenterPoint Energy, Inc.
(CNP) delivered a total return of +88. 3%, compared to +7. 7% for CMS Energy Corporation 5. 6% JRSUB NT 78 (CMSA). Over 10 years, the gap is even starker: CNP returned +133. 4% versus CMSA's +33. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CMSA or CNP?
By beta (market sensitivity over 5 years), CenterPoint Energy, Inc.
(CNP) is the lower-risk stock at -0. 06β versus CMS Energy Corporation 5. 6% JRSUB NT 78's 0. 74β — meaning CMSA is approximately -1360% more volatile than CNP relative to the S&P 500. On balance sheet safety, CMS Energy Corporation 5. 6% JRSUB NT 78 (CMSA) carries a lower debt/equity ratio of 195% versus 2% for CenterPoint Energy, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CMSA or CNP?
By revenue growth (latest reported year), CMS Energy Corporation 5.
6% JRSUB NT 78 (CMSA) is pulling ahead at 13. 6% versus 8. 3% for CenterPoint Energy, Inc. (CNP). On earnings-per-share growth, the picture is similar: CMS Energy Corporation 5. 6% JRSUB NT 78 grew EPS 6. 0% year-over-year, compared to 1. 3% for CenterPoint Energy, Inc.. Over a 3-year CAGR, CNP leads at 0. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CMSA or CNP?
CMS Energy Corporation 5.
6% JRSUB NT 78 (CMSA) is the more profitable company, earning 12. 5% net margin versus 11. 2% for CenterPoint Energy, Inc. — meaning it keeps 12. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CNP leads at 22. 6% versus 20. 2% for CMSA. At the gross margin level — before operating expenses — CMSA leads at 60. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CMSA or CNP more undervalued right now?
On forward earnings alone, CMS Energy Corporation 5.
6% JRSUB NT 78 (CMSA) trades at 5. 7x forward P/E versus 21. 9x for CenterPoint Energy, Inc. — 16. 1x cheaper on a one-year earnings basis.
08Which pays a better dividend — CMSA or CNP?
All stocks in this comparison pay dividends.
CMS Energy Corporation 5. 6% JRSUB NT 78 (CMSA) offers the highest yield at 10. 0%, versus 2. 1% for CenterPoint Energy, Inc. (CNP).
09Is CMSA or CNP better for a retirement portfolio?
For long-horizon retirement investors, CenterPoint Energy, Inc.
(CNP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 06), 2. 1% yield, +133. 4% 10Y return). Both have compounded well over 10 years (CNP: +133. 4%, CMSA: +33. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CMSA and CNP?
Both stocks operate in the Utilities sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CMSA is a small-cap deep-value stock; CNP is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.